Fin Cascade
Get Android appGet iOS app

Prices as of 8 Oct 2026 close · Not investment advice

Valiant Organics Limited

NSE: VALIANTORGSpecialty ChemicalsShort-term ASM stage 1

Share price

₹450.60

-6.10% close of 8 Oct 2026

Market cap ₹1,262 CrP/E 24.7

Business score

How strong the business is, in one number. The parts behind it are in Pro.

50

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹1,262 Cr

P/E ratio

24.7

P/B ratio

1.7

ROCE

5.5%

ROE

3.5%

Dividend yield

0.0%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹496.8052-week low ₹197.64

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 1.4% over the past year, and -1.5% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 15.8% to 13.0% over the last four years.

Whether it grew faster than its sector

It grew -1.5% a year against a sector median of 10.2% — 11.7 percentage points slower.

Room to re-rate, or risk of de-rating

At 24.7× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 53.0×, across 5 companies. It is against its own five-year median of 20.9×, the 66th percentile of its own range.

Whether growth justifies the valuation

Its earnings are falling, so growth cannot justify the price.

Profit growthPrice per ₹1 profitPer 1% growth
Valiant Organics Limited — this one-33%/yr24.7×—
Gujarat Fluorochemicals Limited-24%/yr79.0×—
Navin Fluorine International Limited21%/yr53.0×₹2.5
Aether Industries Limited20%/yr96.7×₹4.8
Deepak Nitrite Limited-13%/yr27.0×—
Atul Limited9%/yr21.6×₹2.4

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Specialty Chemicals), it ranks 59 of 73 on returns, 66 of 72 on growth, 39 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 5.5% on capital, ahead of 19% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹439 crore of cash from the business, spent ₹379 crore on plant and equipment, and returned ₹11 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 8 years, about 125 arrived as cash (before interest, which is why it can exceed the profit). Its cash comes back faster than it used to: it went from being waiting 21 days for its cash to waiting 0 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

7 of 9 checks clear · 78%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 12 Aug 2026 · Consolidated · Unaudited

Revenue

₹232 Cr

Revenue vs last year

+13.5%

Revenue vs last quarter

+6.2%

Net profit

₹29 Cr

Profit vs last year

+265.8%

Profit vs last quarter

+82.9%

Net margin

12.6%

EPS

₹10.44

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹1,262 Cr
Prev close
₹450.60
52w High
₹505
52w Low
₹195
Enterprise value
₹1,516 Cr
Beta
1.1
Price CAGR 1y
50.0%
Price CAGR 3y
1.0%
Price CAGR 5y
-21.0%
Price CAGR 10y
—

Ratios

Return on assets
2.7%
PEG ratio
-0.8
P/E ratio
24.7
P/B ratio
1.7
EV / EBITDA
14.9
Industry P/E
32.7
ROCE
5.5%
ROCE 5y average
8.8%
ROE
3.5%
Debt / Equity
0.3
Interest coverage
3.3
Dividend yield
0.0%
ROE 3y average
1.0%
ROE last year
4.0%

Annual P&L

Annual revenue
₹739 Cr
Annual profit
₹33 Cr
Operating margin
12.0%
Net profit margin
4.5%
EBITDA margin
11.8%
Sales growth 3y
-11.1%
Sales growth 5y
-0.4%
Profit growth 3y
-33.0%
Profit growth 5y
-26.0%
EPS
₹11.9
Sales growth TTM
1.0%
Profit growth TTM
895.0%
Dividend payout
0.0%

Quarter P&L

Sales latest quarter
₹232 Cr
Profit latest quarter
₹29 Cr
YoY quarterly sales growth
13.3%
YoY quarterly profit growth
262.5%
OPM latest quarter
18.0%

Balance Sheet

Book Value
₹271
Face Value
₹10.0
Total debt
₹256 Cr
Total cash
₹2 Cr
Borrowings
₹256 Cr
Reserves / Equity
26.1

Cash Flow

Operating cash flow
₹92 Cr
Free cash flow
₹59 Cr
FCF yield
3.2%
Net cash flow
-₹5 Cr

Shareholding

Promoter holding
37.9%
FII holding
0.2%
DII holding
0.0%
Public holding
61.9%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Pidilite Inds.1,469.3056.41,49,6540.77883.528.24,551.621.331.0
Gujarat Fluoroch4,441.0079.048,7840.07219.021.41,588.024.09.6
Navin Fluo.Intl.8,410.0054.343,1560.18243.3107.71,045.144.121.0
Aether Industri.1,749.0596.723,2150.0062.828.0326.627.311.9
Deepak Nitrite1,581.0027.221,5640.46345.0207.52,577.636.411.4
Atul5,920.0021.917,4300.50253.992.01,848.025.014.9
Aarti Industries478.7533.217,3660.20155.0256.52,387.042.56.9
Valiant Organics452.3525.11,2680.0029.3254.3231.513.35.5
Median350.5028.11,0430.2313.551.6174.426.013.7

Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales202203141177168160187204204157159218232
Expenses178188139179152159172183180136146191190
Material Cost1371259698122150
Change in Inventories-5.420.19-10-6.8711-17
Purchases of Stock-in-Trade0.820.140.051.230.510.20
Employee Cost111212121313
Other Expenses404238394543
Operating Profit24153-216115212521132642
OPM %127.631.83-1.239.250.468.201012138.291218
Other Income940-70361207511
Exceptional items (within Other Income)0005.7200
Interest4447586564535
Depreciation99999999910101010
Profit before tax206-10-252-146711761837
Tax %2526-20-20128-914432624381020
Net Profit155-8-20-1-12548641629
EPS in Rs4.571.58-2.86-7.32-0.22-4.631.981.502.932.021.305.6110
Diluted EPS in Rs1.522.932.021.305.6110

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6926757551,1531,052723719739766
Expenses511494549948888686665652663
Material Cost440442
Change in Inventories4.46-6.22
Purchases of Stock-in-Trade131.94
Employee Cost4549
Other Expenses163164
Operating Profit181181205205164375387102
OPM %2627271816571213
Other Income866713691323
Exceptional items (within Other Income)05.72
Interest43561116241817
Depreciation141621302935364040
Profit before tax171168185176137-8.692.154268
Tax %2925292725-326021
Net Profit121126131128103-8.40-3.433354
EPS in Rs10451424232-3.04-1.341219
Diluted EPS in Rs-1.2412
Dividend Payout %6111283000

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
—
5 years
-0%
3 years
-11%
TTM
1%

Compounded profit growth

10 years
—
5 years
-26%
3 years
-33%
TTM
895%

Stock price CAGR

10 years
—
5 years
-21%
3 years
1%
1 year
50%

Return on equity

10 years
—
5 years
6%
3 years
1%
Last year
4%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital612272727282828
Reserves254374475586662702697731
Borrowings77140209364274257249256
Other Liabilities112143165216276262209217
Minority Interest0.00-0.01
Total Liabilities4486698761,1921,2391,2481,1831,232
Fixed Assets150276510543670643657695
CWIP661294611271866621
Investments122368419994151
Other Assets221241314529457420367365
Total Assets4486698761,1921,2391,2481,1831,232

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity76161113-31238845692
Cash from Investing Activity-86-184-156-124-143-65-21-86
Cash from Financing Activity12749167-112-23-32-11
Net Cash Flow-95512-17-44-5
Free Cash Flow-13-44-58-153108192759

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days7572761028810690120
Inventory Days4442635468887177
Days Payable6982936389159119102
Cash Conversion Cycle5032459367344296
Working Capital Days4620-12111-3-100
ROCE %39302114135

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters383838383838383838383838
FIIs0.190.691.141.351.340.820.370.210.210.220.280.21
DIIs0.920.870.430.090.080000000
Public616161616161626262626262
No. of Shareholders48,59849,05050,46050,02248,18949,01748,07744,29343,27442,31140,92840,526

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +41.2% (₹319.15 → ₹450.60)Brick size ₹27.06 (fixed)Bricks 15
₹300₹400₹451Nov '25May '26
Price moved up one brickPrice moved down one brickLast close ₹450.60 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

254inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

81,86,065inr

2026-03-31

News

News and filings about Valiant Organics Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • Chlorine
  • ONCB (Ortho Nitro Chloro Benzene)
  • PNCB (Para Nitro Chloro Benzene)
  • Phenol

Buys drug ingredients from

Sells drug ingredients to

Sells to

  • Aarti Drugs Limited · Specialty chemical intermediates (FY23 sale ~Rs 16.5 cr)
  • Aarti Industries Limited · Chlorophenol & benzene derivatives (~40% of production sold to group co)
  • Aarti Pharmalabs Limited · Pharma intermediates / specialty chemicals (FY23 sale ~Rs 4.5 cr)
  • Anupam Rasayan India Limited · Specialty chemical / agrochem-dye intermediates
  • Clariant Chemicals (India) Ltd. · Specialty chemicals / dye intermediates
  • Colourtex Industries · Dye intermediates
  • Lanxess India Private Limited · Specialty chemicals
  • Spectrum Dyes & Chemicals Pvt. Ltd. · Dye/pigment intermediates
  • Valiant Laboratories Limited · Para Amino Phenol (PAP) — ~85% of PAP output, feed for paracetamol

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Specialty Chemicals
Classification
Chemicals › Specialty Chemicals
ISIN
INE565V01010

Business segments

  • Speciality Chemical Division · 78%
  • Pharma Division · 22%

Plants

  • Valiant Organics Ahmedabad Plant (Sulphonation & Acetylation)
  • Valiant Organics Jhagadia Unit 1 (Hydrogenation & Methoxylation)
  • Valiant Organics Jhagadia Unit 2 (PAP Hydrogenation)
  • Valiant Organics Sarigam Plant (Chlorination)
  • Valiant Organics Tarapur Plant (Ammonolysis)
  • Valiant Organics Vapi Plant (Ammonolysis)

News impact

Big market events that reach Valiant Organics Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

10 Feb 2023interim₹1
20 Sep 2022unspecified₹3.5
24 Dec 2020bonus₹0
24 Nov 2020interim₹5

Splits, bonuses & buybacks

  • daily-prices repair: 7 rows from NSE's archive (replace 2, delete 0, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023

Insider trades

DisclosedWhoTypeSharesValue ₹ Cr
16 Sep 2026Vicky Hemchand Gala · PromoterBUY3,5000.00
8 Sep 2026Siddharth Dinesh Shah HUF · Designated PersonBUY1,0000.03
5 Sep 2026Siddharth Dinesh Shah HUF · Designated PersonBUY2,0000.06
5 Sep 2026Ishita Siddharth Shah · Designated PersonBUY2,0000.06
5 Sep 2026Siddharth Dinesh Shah HUF · Designated PersonBUY1,5000.05
5 Sep 2026Ishita Siddharth Shah · Designated PersonBUY6000.02
5 Sep 2026Siddharth Dinesh Shah HUF · Designated PersonSELL5000.02
5 Sep 2026Ishita Siddharth Shah · Designated PersonBUY4000.01

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.